# Leukotriene Antagonists


Selectively inhibit the cysteinyl leukotriene receptor, increased activity of which is involved in airway oedema and bronchial smooth muscle constriction.

|Property|Montelukast|
|--|--|
|**Class**|Leukotriene Antagonist|
|**Uses**| Asthma, allergic rhinitis|
|**Route of Administration**|PO|
|**Dosing**|10mg daily|
|**Absorption**|64% PO bioavailability|
|**Distribution**|t~0.5~ 5 hours, >99% protein bound|
|**Metabolism**|Hepatic by CYP3A4 |
|**Elimination**|Predominantly faecal|
|**Resp**|Bronchodilatation|

---
## References

1. . Lexicomp. Montelukast: Drug information. In: UpToDate, Post, TW (Ed), UpToDate, Waltham, MA, 2017.